Third artificial heart patient suffers stroke:
This article was originally published in Clinica
Executive Summary
The third patient to receive Abiomed's AbioCor artificial heart has suffered a stroke, but is recovering well, said physicians from the Texas Heart Institute and St Luke's Episcopal Hospital said last week. Abiomed of Danvers, Massachusetts, said last month that it planned to modify the design of its fully implantable heart, as a question-mark hangs over one specific component that could potentially cause a stroke in human recipients (see Clinica No 994, p 21). Three of the five patients to receive the AbioCor heart to date have suffered strokes.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.